Nabriva Therapeutics Plc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 06/30/23 Q2

Late quarterly filing notification for Q2 2023

ended 03/31/23 Q1

Late quarterly filing notification for Q1 2023

ended 12/31/22 FY 2022

Prospectuses and Registrations Filter

Securities registration termination

Updated info for already-effective prospectus

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Hogan H Michael III

Gelone Steven P.

Schroeder Theodore R

Gelone Steven P.

News Filter

Material Definitive Agreement, Termination of Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Change in Directors, Officers or Compensation, Other Events, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Confidential treatment order

Notice of effectiveness

Correspondence with the SEC

Confidential treatment order